货号:GS40776
Varisacumab is a recombinant human IgG1 kappa monoclonal antibody targeting vascular endothelial growth factor A (VEGFA), a key cytokine that drives angiogenesis and vascular permeability. It binds to VEGFA to block its interaction with VEGF receptors (VEGFR-1 and VEGFR-2), thereby inhibiting pathological blood vessel formation and leakage. It is being developed for the treatment of neovascular age-related macular degeneration (nAMD) and other retinal vascular diseases.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
周璐